Cargando…

Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)

BACKGROUND: Vitiligo is a multi-factorial pigmentary skin disorder. Recently, the importance of emotional and psychological issues is proposed in incidence, progression, relapse and remission of vitiligo. There are limited studies conducted in developing countries, which assess life quality of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedayat, Kosar, Karbakhsh, Mojgan, Ghiasi, Maryam, Goodarzi, Azadeh, Fakour, Yousef, Akbari, Zahra, Ghayoumi, Afsaneh, Ghandi, Narges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897932/
https://www.ncbi.nlm.nih.gov/pubmed/27267598
http://dx.doi.org/10.1186/s12955-016-0490-y
_version_ 1782436264795963392
author Hedayat, Kosar
Karbakhsh, Mojgan
Ghiasi, Maryam
Goodarzi, Azadeh
Fakour, Yousef
Akbari, Zahra
Ghayoumi, Afsaneh
Ghandi, Narges
author_facet Hedayat, Kosar
Karbakhsh, Mojgan
Ghiasi, Maryam
Goodarzi, Azadeh
Fakour, Yousef
Akbari, Zahra
Ghayoumi, Afsaneh
Ghandi, Narges
author_sort Hedayat, Kosar
collection PubMed
description BACKGROUND: Vitiligo is a multi-factorial pigmentary skin disorder. Recently, the importance of emotional and psychological issues is proposed in incidence, progression, relapse and remission of vitiligo. There are limited studies conducted in developing countries, which assess life quality of patients with vitiligo. The aim of this study was the application and evaluation of a disease-specific quality of life index in Iranian patients, for the first time. METHODS: This cross-sectional biphasic study was conducted on 25 patients as a pilot and another 173 patients as the main study group, in Razi Hospital, Tehran, Iran, 2013–2014. Persian version of Vitiligo Quality of Life index (VitiQoL) was developed with backward-forward method. Based on the pilot study, the validity and reliability were assessed. The Vitiligo Area and Score Index (VASI), VitiQoL, and their relationship, demographic and clinical characteristic of patients were measured. RESULTS: The Mean and standard deviation of the VitiQoL score was 30.5 ± 14.5 (range 0–60 in Persian version). There was a significant relationship between VASI score and VitiQoL (p = 0.015, r = 0.187). Confirmatory factor analysis revealed three important factors within VitiQoL: participation limitation, stigma, and behavior. In subscale analysis based on behavior factor, female patients had poorer quality of life (p = 0.02). Concomitant psychiatric problems, e.g. anxiety and depression, were not associated with QOL; however, they were near to being meaningful (p = 0.06, r = 0.14). CONCLUSION: VitiQoL is a valid index in estimating life quality of vitiligo patients and has proper relation to disease severity. Focusing on patient’s life quality is an important entity in the management of vitiligo patients; relevant supportive group-based consultations and therapies are also important arms when approaching vitiligo. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0490-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4897932
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48979322016-06-09 Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL) Hedayat, Kosar Karbakhsh, Mojgan Ghiasi, Maryam Goodarzi, Azadeh Fakour, Yousef Akbari, Zahra Ghayoumi, Afsaneh Ghandi, Narges Health Qual Life Outcomes Research BACKGROUND: Vitiligo is a multi-factorial pigmentary skin disorder. Recently, the importance of emotional and psychological issues is proposed in incidence, progression, relapse and remission of vitiligo. There are limited studies conducted in developing countries, which assess life quality of patients with vitiligo. The aim of this study was the application and evaluation of a disease-specific quality of life index in Iranian patients, for the first time. METHODS: This cross-sectional biphasic study was conducted on 25 patients as a pilot and another 173 patients as the main study group, in Razi Hospital, Tehran, Iran, 2013–2014. Persian version of Vitiligo Quality of Life index (VitiQoL) was developed with backward-forward method. Based on the pilot study, the validity and reliability were assessed. The Vitiligo Area and Score Index (VASI), VitiQoL, and their relationship, demographic and clinical characteristic of patients were measured. RESULTS: The Mean and standard deviation of the VitiQoL score was 30.5 ± 14.5 (range 0–60 in Persian version). There was a significant relationship between VASI score and VitiQoL (p = 0.015, r = 0.187). Confirmatory factor analysis revealed three important factors within VitiQoL: participation limitation, stigma, and behavior. In subscale analysis based on behavior factor, female patients had poorer quality of life (p = 0.02). Concomitant psychiatric problems, e.g. anxiety and depression, were not associated with QOL; however, they were near to being meaningful (p = 0.06, r = 0.14). CONCLUSION: VitiQoL is a valid index in estimating life quality of vitiligo patients and has proper relation to disease severity. Focusing on patient’s life quality is an important entity in the management of vitiligo patients; relevant supportive group-based consultations and therapies are also important arms when approaching vitiligo. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0490-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-07 /pmc/articles/PMC4897932/ /pubmed/27267598 http://dx.doi.org/10.1186/s12955-016-0490-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hedayat, Kosar
Karbakhsh, Mojgan
Ghiasi, Maryam
Goodarzi, Azadeh
Fakour, Yousef
Akbari, Zahra
Ghayoumi, Afsaneh
Ghandi, Narges
Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title_full Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title_fullStr Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title_full_unstemmed Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title_short Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
title_sort quality of life in patients with vitiligo: a cross-sectional study based on vitiligo quality of life index (vitiqol)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897932/
https://www.ncbi.nlm.nih.gov/pubmed/27267598
http://dx.doi.org/10.1186/s12955-016-0490-y
work_keys_str_mv AT hedayatkosar qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT karbakhshmojgan qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT ghiasimaryam qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT goodarziazadeh qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT fakouryousef qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT akbarizahra qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT ghayoumiafsaneh qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol
AT ghandinarges qualityoflifeinpatientswithvitiligoacrosssectionalstudybasedonvitiligoqualityoflifeindexvitiqol